HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jinhong Chang Selected Research

Type I DNA Topoisomerases (Topoisomerase I)

1/2019Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jinhong Chang Research Topics

Disease

40Infections
01/2022 - 04/2007
16Virus Diseases (Viral Diseases)
01/2022 - 05/2007
16Chronic Hepatitis B
12/2021 - 09/2010
8Hepatocellular Carcinoma (Hepatoma)
12/2021 - 08/2008
4Porcine Reproductive and Respiratory Syndrome (PRRS)
01/2022 - 01/2009
4Hepatitis B
10/2020 - 12/2012
4Bites and Stings (Sting)
12/2019 - 02/2015
4Dengue (Dengue Fever)
01/2018 - 02/2012
3Yellow Fever
10/2020 - 12/2016
3Viral Hemorrhagic Fevers (Viral Hemorrhagic Fever)
01/2018 - 06/2013
3Fever (Fevers)
01/2018 - 06/2013
2Coronavirus Infections
01/2022 - 01/2020
2Disease Progression
12/2021 - 08/2014
2Neoplasms (Cancer)
12/2019 - 11/2017
2Diarrhea
04/2013 - 04/2009
2Viremia
11/2011 - 01/2011
1COVID-19
01/2022
1Flavivirus Infections
01/2022
1Leukemia
01/2020
1Carcinogenesis
10/2019
1Lassa Fever (Fever, Lassa)
01/2019
1Craniosynostoses (Craniosynostosis)
12/2018
1Acrocephalosyndactylia (Apert Syndrome)
12/2018
1Japanese Encephalitis
01/2018
1Ebola Hemorrhagic Fever
01/2018
1Marburg Virus Disease
02/2017
1Body Weight (Weight, Body)
12/2016
1Disease Susceptibility (Diathesis)
01/2015
1Persistent Infection
08/2014
1Common Cold
05/2014
1Fibrosis (Cirrhosis)
06/2013
1Inflammation (Inflammations)
01/2012

Drug/Important Bio-Agent (IBA)

36Antiviral Agents (Antivirals)IBA
01/2022 - 02/2008
15Proteins (Proteins, Gene)FDA Link
10/2020 - 05/2007
12CytokinesIBA
01/2022 - 01/2009
9InterferonsIBA
01/2022 - 08/2010
7Pattern Recognition ReceptorsIBA
01/2022 - 01/2009
7DNA (Deoxyribonucleic Acid)IBA
12/2021 - 08/2014
6GlucosidasesIBA
01/2018 - 01/2011
5Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2021 - 09/2015
5Viral DNAIBA
10/2020 - 06/2013
4Toll-Like Receptors (Toll-Like Receptor)IBA
01/2022 - 01/2009
4Interferon-alpha (Interferon Alfa)IBA
08/2014 - 02/2008
4SugarsIBA
06/2013 - 04/2009
3RNA (Ribonucleic Acid)IBA
01/2022 - 09/2013
3Interferon Type IIBA
01/2022 - 01/2012
3VaccinesIBA
01/2022 - 12/2016
3sodium-bile acid cotransporterIBA
12/2021 - 10/2017
3Surface Antigens (Surface Antigen)IBA
02/2021 - 01/2017
3Membrane Proteins (Integral Membrane Proteins)IBA
12/2019 - 08/2010
3cyclic guanosine monophosphate-adenosine monophosphateIBA
12/2019 - 10/2017
3Pharmaceutical PreparationsIBA
11/2017 - 03/2011
2Viral AntigensIBA
12/2021 - 01/2017
2AntibodiesIBA
12/2021 - 02/2021
2Viral ProteinsIBA
12/2021 - 10/2019
2Biological ProductsIBA
01/2020 - 07/2012
2Interferon-gamma (Interferon, gamma)IBA
01/2020 - 09/2010
2DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
01/2019 - 01/2016
2glucosidase IIBA
01/2018 - 01/2015
2ureido-N-hexyl deoxynojirimycinIBA
01/2018 - 02/2017
2Tetracycline (Achromycin)FDA LinkGeneric
10/2017 - 09/2013
2ProdrugsIBA
02/2017 - 09/2013
2Imino SugarsIBA
06/2013 - 01/2011
1Viral RNAIBA
01/2022
1Therapeutic UsesIBA
01/2022
1Exonucleases (3' 5' Exonuclease)IBA
12/2021
1Capsid Proteins (Capsid Protein)IBA
10/2020
1STAT1 Transcription FactorIBA
01/2020
1AntigensIBA
01/2020
1platelet protein P47 (pleckstrin)IBA
01/2020
1Protein SIBA
01/2020
1EnzymesIBA
01/2019
1Viral Envelope ProteinsIBA
01/2019
1Glycoproteins (Glycoprotein)IBA
01/2019
1Type I DNA Topoisomerases (Topoisomerase I)IBA
01/2019
1Small Interfering RNA (siRNA)IBA
01/2019
1AphidicolinIBA
01/2019
1Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
12/2018
12',3'-dideoxyguanosineIBA
12/2018
1Firefly LuciferasesIBA
11/2017
1LuciferasesIBA
11/2017
1Circular DNAIBA
10/2017
1LigandsIBA
10/2017
1Janus KinasesIBA
10/2017
1Messenger RNA (mRNA)IBA
01/2017
1benzamideIBA
01/2017
1BenzodiazepinesIBA
12/2016
1Nucleic Acid Synthesis InhibitorsIBA
01/2016
1Ribonuclease H (RNase H)IBA
01/2016
1pgRNAIBA
01/2016
1ChemokinesIBA
02/2015
1vadimezanIBA
02/2015
1Toll-Like Receptor AgonistsIBA
02/2015
1FluorineIBA
06/2013
1AmidesIBA
04/2013
1N-dodecyl-L-lysine amideIBA
04/2013
16H- 6- imino- (2,3,4,5- tetrahydropyrimido)(1,2- c)- (1,3)benzothiazineIBA
02/2012

Therapy/Procedure

16Therapeutics
01/2022 - 02/2008
2Immunotherapy
10/2017 - 01/2017
2Oral Administration
12/2016 - 01/2011